Literature DB >> 15583925

[Otological findings in adults with isolated cleft palate or cleft lip, jaw, and palate].

V Gudziol1, W J Mann.   

Abstract

BACKGROUND: Children with cleft palate often develop middle ear ventilation disorders due to chronic Eustachian tube dysfunction. This may lead to hearing loss. The insertion of ventilation tubes is a widely accepted measure to avoid sequelae of middle ear ventilation disorders and hearing loss. On the other hand, long-term therapy with ventilation tubes may inflict iatrogenic complications. The objective of the study was the evaluation of otoscopic and audiometric long-term findings in adult cleft patients who had been treated with ventilation tubes since childhood when chronic otitis media with effusion had been observed. PATIENTS AND METHODS: Ninety-two cleft palate patients had been followed up otoscopically and audiometrically for years. The average age was 19.3 years (minimum: 14, maximum: 39 years) at the time the last status was taken.
RESULTS: Otoscopy revealed a perforation of the tympanic membrane in 3.8% of the 184 ears. 12% of the patients developed cholesteatoma, however three quarters of these occurred after age 11. 86.4% of the 92 patients had normal hearing in pure tone audiometry.
CONCLUSION: Compared with adult cleft patients who did not receive ventilation tubes, our patients had a similar low incidence of eardrum perforations but a higher incidence of cholesteatomas while hearing loss occurred less often. Whether the higher incidence of cholesteatomas is caused iatrogenically or due to a longer follow-up period remains unclear. Whether the use of long-lasting ventilation tubes affects the incidence of cholesteatomas must be proved in further studies.

Entities:  

Mesh:

Year:  2004        PMID: 15583925     DOI: 10.1007/s10006-004-0574-4

Source DB:  PubMed          Journal:  Mund Kiefer Gesichtschir        ISSN: 1432-9417


  22 in total

1.  Long-term otologic features of cleft palate patients.

Authors:  P Möller
Journal:  Arch Otolaryngol       Date:  1975-10

2.  A LONGITUDINAL STUDY OF EAR DISEASE AND HEARING LOSS IN PATIENTS WITH CLEFT LIPS AND PALATES.

Authors:  M D GRAHAM
Journal:  Ann Otol Rhinol Laryngol       Date:  1964-03       Impact factor: 1.547

3.  Long-term otologic status of older cleft palate patients.

Authors:  J A Koempel; A Kumar
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

4.  Eustachian tube obstruction in the infant with cleft palate.

Authors:  C D Bluestone
Journal:  Ann Otol Rhinol Laryngol       Date:  1971-08       Impact factor: 1.547

5.  [Otorhinologic and endoscopic findings in cleft palate patients with special reference to velopharyngoplasty].

Authors:  E Schleier; D Schumann
Journal:  Stomatol DDR       Date:  1979-04

6.  Cholesteatomas associated with ventilation tube insertion.

Authors:  A Golz; D Goldenberg; A Netzer; L M Westerman; S T Westerman; M Fradis; H Z Joachims
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1999-07

7.  Hearing loss in tympanosclerosis caused by grommets.

Authors:  M Tos; S E Stangerup
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1989-08

8.  [Ear findings in patients with cleft lip-jaw-palate. Experiences from a cleft consultation].

Authors:  G S Godbersen
Journal:  Laryngol Rhinol Otol (Stuttg)       Date:  1984-03

9.  A prospective randomized study of four commonly used tympanostomy tubes.

Authors:  M T Weigel; M Y Parker; M M Goldsmith; D S Postma; H C Pillsbury
Journal:  Laryngoscope       Date:  1989-03       Impact factor: 3.325

10.  Consequences of unremitting middle-ear disease in early life. Otologic, audiologic, and developmental findings in children with cleft palate.

Authors:  T W Hubbard; J L Paradise; B J McWilliams; B A Elster; F H Taylor
Journal:  N Engl J Med       Date:  1985-06-13       Impact factor: 91.245

View more
  1 in total

1.  [Chronic eustachian tube dysfunction and its sequelae in adult patients with cleft lip and palate].

Authors:  V Gudziol; W J Mann
Journal:  HNO       Date:  2006-09       Impact factor: 1.284

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.